Selling digital health to a health system, payer, or large employer requires winning over a buying committee with fundamentally different priorities, across a sales cycle measured in quarters rather than weeks. Standard B2B demand gen playbooks designed for one economic buyer do not create pipeline that reliably closes in this category. We build demand generation around the actual committee and sales cycle.
The Challenge
Your content addresses one stakeholder, while the deal must persuade at least three
A clinical champion needs evidence and workflow fit. An IT and security reviewer needs data architecture and compliance detail. A procurement or finance stakeholder needs ROI and total cost of ownership. Most demand gen content is written for a single generic buyer persona, which means it under-serves at least two of the three people who actually have to say yes before a deal closes.
Your pipeline metrics assume a sales cycle that differs from how health systems and payers really buy
A standard B2B SaaS demand gen program expects leads to convert to pipeline to closed deals within a quarter or two. Enterprise health buyers often run procurement cycles of six months to two years, involving security reviews, clinical pilots, and budget cycles tied to their own fiscal calendar. Programs measured against a standard SaaS velocity benchmark look like they are failing when they are actually on pace for this category.
Security and compliance review can end a deal after months of pipeline effort, yet most demand gen programs do not address it until legal gets involved
A health system's IT security review can surface concerns about data handling, integration architecture, or compliance posture that were never addressed anywhere in the buyer's journey, and a deal that looked like it was close to closing dies in security review instead. Demand gen programs that do not proactively surface security and compliance credibility earlier in the funnel are setting up late-stage deal collapse as a routine outcome instead of an exception.
You are competing for attention with internal build decisions and incumbent EHR vendors, not only direct competitors
A health system evaluating your product is often also weighing whether to build the capability internally or extend an existing EHR or vendor relationship instead. Demand gen content that only differentiates against named direct competitors misses this larger competitive frame, and a campaign that wins the head-to-head comparison can still lose to "we'll just have our EHR vendor add that" if that alternative was never addressed.
How We Support You
We begin by mapping the actual buying committee for your specific deal type – identifying who the clinical champion, security reviewer, procurement stakeholder, and executive sponsor usually are, and what each needs to see before supporting the next step. That becomes the basis for every content and campaign decision that follows.
We then create a content and campaign architecture with separate tracks for every committee member: clinical evidence and workflow content for the champion, data architecture and compliance documentation for security review, and ROI and total cost of ownership analysis for procurement and finance. One deal requires all three to advance in parallel, rather than relying on a generic asset to serve everyone at once.
We structure pipeline reporting and program measurement around the actual enterprise health sales cycle – typically six months to two years – so leadership assesses the program against a realistic velocity benchmark, not a standard SaaS quarter-over-quarter expectation that makes an on-pace team appear to be failing.
Security and compliance credibility is introduced early in the funnel instead of being left to legal once a deal reaches a late stage. We incorporate data architecture and compliance content into the middle-funnel nurture sequence so the security reviewer has confidence before the formal review begins, lowering the risk of a late-stage collapse.
Competitive positioning directly addresses build-versus-buy decisions and the incumbent-vendor-extension alternative, rather than focusing only on named direct competitors. That is often the real choice facing a health system buying committee, and campaigns that overlook it are arguing against the wrong opponent.
Unlike a standard B2B demand gen engagement, we design the entire program for the actual multi-stakeholder committee and multi-quarter cycle that defines this category, rather than applying a SaaS demand gen framework and hoping its fundamentals carry over.
What we deliver
- Buying committee map identifying clinical, security, procurement, and executive stakeholder needs by deal type
- Stakeholder-specific content and campaign tracks running in parallel rather than one generic buyer asset
- Pipeline reporting benchmarked against realistic enterprise health sales cycle timing
- Middle-funnel security and compliance credibility content surfaced before formal review begins
- Competitive positioning that addresses build-versus-buy and incumbent vendor extension, not just named competitors
Most digital health demand gen programs fail because of a measurement problem before a content problem – a program tracking toward an eighteen-month enterprise sales cycle is cut after two quarters because it was judged against a benchmark created for an entirely different business.
Our Methodology
We operate digital health demand generation as a 90-day sprint that establishes the foundation, followed by ongoing execution aligned with a realistic cycle. During the first 30 days, we map your buying committee by deal type and audit existing content against each stakeholder's actual needs. Days 30 through 60 focus on building stakeholder-specific content and campaign tracks, including early-funnel security and compliance credibility materials. From days 60 through 90, we launch the complete program and establish pipeline reporting benchmarked against your actual sales cycle length.
Rather than acting like a standard B2B demand gen agency that applies a SaaS framework with quarterly pipeline targets, we design the program around the real multi-stakeholder committee and multi-quarter cycle involved in sales to health systems, payers, and large employers. Success is measured through committee-level engagement and deal progression across every real gate – clinical validation, security review, procurement approval – rather than top-of-funnel lead volume alone.
Our Approach
The first 30 days are spent mapping the actual buying committee for your product and deal size, then auditing your current pipeline to identify where deals truly stall – clinical, security, or procurement.
From days 30 through 60, we create stakeholder-specific content tracks and launch the initial campaigns, deliberately moving security and compliance content earlier in the funnel than most programs do. We need access to the people on your team responsible for compliance and security documentation, because this content must be accurate and up to date to remain credible.
Days 60 through 90 bring the full program to scale and establish pipeline reporting benchmarked against your actual sales cycle, ensuring progress is measured honestly rather than against an unrealistic quarterly goal. Because of the enterprise health sales cycle, most engagements last six months or more, with ongoing refinement as deals progress through each stage and expose remaining content or positioning gaps.
Our cadence includes a weekly pipeline review centered on stage progression by committee member, along with a monthly program-level report on content performance and deal velocity relative to the realistic benchmark.
- Pipeline that moves through clinical, security, and procurement gates instead of stalling at one
- Reduced late-stage deal collapse from unaddressed security and compliance concerns
- Pipeline reporting leadership can actually trust against the real sales cycle
- Competitive positioning that wins against build-versus-buy, not just named competitors
If your digital health company needs demand generation leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
What does a demand generation engagement cost for a digital health company?
Pricing varies based on the number of buying committee tracks requiring content and the complexity of your compliance and security documentation. Companies targeting one buyer type pay less than those selling concurrently to health systems, payers, and large employers.
How soon will we see results from a demand generation engagement?
Initial campaigns and content tracks generally launch within 60 days. Because of the actual enterprise health sales cycle, meaningful pipeline progress through security and procurement gates may take six months to a year to become visible. We communicate that expectation clearly upfront instead of promising SaaS-standard velocity.
How will your demand gen team collaborate with our sales and clinical staff?
We partner directly with your sales team to identify where deals genuinely stall by committee stage, while working with clinical and compliance staff to develop accurate, credible content for the champion and security reviewer tracks. Regular access to both groups is necessary throughout the engagement.
How is Winston Francois different from a typical B2B demand gen agency?
Most demand gen agencies use a SaaS framework created for one buyer and a one-to-two-quarter sales cycle. We design the program around the actual multi-stakeholder buying committee and multi-quarter cycle involved in health system and payer sales, including security and compliance content that most programs do not address.
How is ROI measured for a demand generation engagement?
We track deal progression across every actual buying-committee gate – clinical validation, security review, procurement approval – against a realistic enterprise health sales timeline, rather than measuring top-of-funnel lead volume against a standard SaaS quarter.
Which type of digital health company is the best fit for this service?
This service is designed for digital health companies selling to health systems, payers, or large employers through a multi-stakeholder buying process, typically in the 5M to 100M ARR range, with an established sales team but weak pipeline conversion. Begin with a strategy call and a review of where your existing pipeline is stalling.
